http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-001996-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_634715a790f7ef0163a61e9f364bebcd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
filingDate 1995-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1998-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-001996-A1
titleOfInvention COMPOUNDS FOR THE INHIBITION OF THE SECRETION OF GASTRIC ACID, PHARMACEUTICAL FORMULATIONS THAT INCLUDE IT, ITS USE TO PREPARE A MEDICINAL PRODUCT AND METHODS OF TREATMENT OR PROPHYLAXIS FOR GASTROINTESTINAL INFLAMMATORY DISEASES.
abstract The present invention relates to certain salts of the compound 3-butyryl-4- (2-methylphenylamino) -8- (2-methylsulfinylethoxy) quinoline, which inhibits exogenously or endogenously stimulated gastric acid secretion, and which can therefore be used to the prevention and treatment of inflammatory gastrointestinal diseases.
priorityDate 1994-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421969082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9931393

Total number of triples: 21.